Asborin Inhibits Aldo/Keto Reductase 1A1

ChemMedChem

Volumn 6, Issue 1, 2011, Pages 89-93

  Scholz, Matthias ^a   Steinhagen, Max ^a   Heiker, John T ^a   Beck Sickinger, Annette G ^a   Hey Hawkins, Evamarie ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Acetylation; Aldo keto reductases; Asborin; Carbaboranes; Phamacophores

Indexed keywords

ACETYLSALICYLIC ACID; ALDO KETO REDUCTASE 1A1; ASBORIN; CARBORANE DERIVATIVE; ENZYME; SALBORIN; SALICYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE; IC 50; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ACETATES; ACETYLATION; ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; ASPIRIN; BORON; BORON COMPOUNDS; CATALYTIC DOMAIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA;

EID: 78650551193     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201000368     Document Type: Article

References (24)

1. V. I. Bregadze, I. B. Sivaev, S. A. Glazun, Anti-Cancer Agents Med. Chem. 2006, 6, 75.
2. M. F. Hawthorne, Angew. Chem. 1993, 105, 997; Angew. Chem. Int. Ed. Engl. 1993, 32, 950;
3. M. F. Hawthorne, Angew. Chem. 1993, 105, 997;
4. J. F. Valliant, K. J. Guenther, A. S. King, P. Morel, P. Schaffer, O. O. Sogbein, K. A. Stephenson, Coord. Chem. Rev. 2002, 232, 173.
5. R. C. Reynolds, S. R. Campbell, R. G. Fairchild, R. L. Kisliuk, P. L. Micca, S. F. Queener, J. M. Riordan, W. D. Sedwick, W. R. Waud, Leung, R. W. Dixon, W. J. Suling, D. W. Borhani, J. Med. Chem. 2007, 50, 3283;
6. R. L. Julius, O. K. Farha, J. Chiang, L. J. Perry, M. F. Hawthorne, Proc. Natl. Acad. Sci. USA 2007, 104, 4808.
7. M. Scholz, K. Bensdorf, R. Gust, E. Hey-Hawkins, ChemMedChem 2009, 4, 746.
8. M. Scholz, G. N. Kaluderović, H. Kommera, R. Paschke, J. Will, W. S. Sheldrick, E. Hey-Hawkins, unpublished results.
9. G. P. Hochgesang, S. W. Rowlinson, L. J. Marnett, J. Am. Chem. Soc. 2000, 122, 6514.
10. U. Dhagat, V. Carbone, R. P. Chung, T. Matsunaga, S. Endo, A. Hara, O. El-Kabbani, Med. Chem. 2007, 3, 546.
11. Y. Jin, T. M. Penning, Annu. Rev. Pharmacol. Toxicol. 2007, 47, 263.
12. O. A. Barski, K. H. Gabbay, K. M. Bohren, Biochemistry 1996, 35, 14276.
13. D. K. Wilson, K. M. Bohren, K. H. Gabbay, F. A. Quiocho, Science 1992, 257, 81.
14. T. J. Kubiseski, D. J. Hyndman, N. A. Morjana, T. G. Flynn, J. Biol. Chem. 1992, 267, 6510.
15. I. Tarle, D. W. Borhani, D. K. Wilson, F. A. Quiocho, J. M. Petrash, J. Biol. Chem. 1993, 268, 25687.
16. G. Sanli, J. I. Dudley, M. Blaber, Cell Biochem. Biophys. 2003, 38, 79.
17. M. P. O. Richter, K. Holland-Nell, A. G. Beck-Sickinger, Tetrahedron 2004, 60, 7507.
18. K. Holland-Nell, A. G. Beck-Sickinger, ChemBioChem 2007, 8, 1071.
19. H. P. Kleber, D. Schlee, W. Schöpp, Biochemisches Praktikum: Methoden für Studium, Praxis, Forschung, 5th ed., Gustav Fischer Verlag, Jena, 1997.
20. M. Takahashi, Y. B. Lu, T. Myint, J. Fujii, Y. Wada, N. Taniguchi, Biochemistry 1995, 34, 1433.
21. P. Brožič, J. Cesar, A. Kovač, M. Davies, A. P. Johnson, C. W. Fishwick, T. Lanišnik Rižner, S. Gobec, Chem.-Biol. Interact. 2009, 178, 158;
22. A. B. M. Reddy, S. K. Srivastava, K. V. Ramana, Cytokine 2009, 48, 170;
23. T. L. Rizner, T. Smuc, R. Rupreht, J. Sinkovec, T. M. Penning, Mol. Cell. Endocrinol. 2006, 248, 126.
24. O. A. Barski, K. H. Gabbay, C. E. Grimshaw, K. M. Bohren, Biochemistry 1995, 34, 11264.